34410950 |
cytoplasmic LCOR |
ER |
p=0.001 |
The analysis showed that the the semi-quantitative immunoreactive score for cytoplasmic LCOR was positively correlated with that for ER.(Spearman’s ρ=0.351) |
26308378 |
ATAD2 |
ERα |
p<0.001 |
ATAD2 expression is also negatively correlated with protein expression of hormone receptors ERα |
26308378 |
ATAD2 |
PR |
p<0.001 |
ATAD2 expression is also negatively correlated with protein expression of hormone receptors PR |
26308378 |
ATAD2 |
Androgen Receptor |
p<0.001 |
ATAD2 expression is also negatively correlated with protein expression of hormone receptors Androgen Receptor |
24853175 |
HSF1 |
ERα |
p<0.001 |
both middle and high HSF1 cases were more likely to be ERα positive |
24849812 |
FOXA1 |
PR |
p=0.02 |
Low FOXA1 expression (score index from 0–4) was significantly correlated with loss of PR |
24849812 |
FOXA1 |
ERα |
p=0.003 |
LowFOXA1 expression (score index from 0–4) was significantly correlated with loss of ERα |
23818363 |
hPEBP4 |
PR |
p=0.027 |
A significant negative correlation between the expression of PR and hPEBP4 was noticed in the EEC group |
23818363 |
hPEBP4 |
ER |
p=0.013 |
Significant negative correlation between ER and hPEBP4 was also revealed in EEC |
19396818 |
EphA2 |
ER |
p=.01 |
EphA2 overexpression was associated significantly with low ER expression |
19396818 |
EphA2 |
PR |
p=.006 |
EphA2 overexpression was associated significantly with low PR expression |
34410950 |
cytoplasmic LCOR |
PR |
p=0.005 |
The analysis showed that the IRS for cytoplasmic LCOR was positively correlated with that for PR (Spearman’s ρ=0.289) |
18475299 |
BMI-1 |
oestrogen receptor |
p<0.0001 |
BMI-1 protein expression was significantly weaker in tumours with loss of oestrogen receptor |
18475299 |
BMI-1 |
PR |
p=0.03 |
BMI-1 protein expression was significantly weaker in tumours with progesterone receptors (PR) |
17403429 |
GPR30 |
PR |
p=.05 |
GPR30 correlated negatively with progesterone receptor expression |
16322283 |
EIG121 |
ERa |
p<0.01 |
The level of EIG121
transcripts in the endometrial tumors was highly correlated with the expression of transcripts for ERa.(r = 0.641) |
16322283 |
EIG121 |
progesterone receptor |
p<0.01 |
The level of EIG121
transcripts in the endometrial tumors was highly correlated with the expression of transcripts for progesterone receptor.(r = 0.529) |
35220229 |
PDL-1 |
ER |
p=0.027 |
The absence of the estrogen receptor (p=0.027) and the progesterone receptor (p=0.002) correlated statistically significantly with PD-L1 expression. |
30683081 |
SNF5 |
PR |
|
The overexpression of SNF5 was associated with the PR levels |
29907137 |
GLP-1R |
estrogen receptor |
p<0.001 |
The immunohistological analysis of GLP-1R revealed that the expression of GLP-1R was associated with positive estrogen receptor. |
29907137 |
GLP-1R |
progesterone receptor |
p<0.001 |
The immunohistological analysis of GLP-1R revealed that the expression of GLP-1R was associated with positive progesterone receptor. |
29169184 |
HER2 |
ER/PR |
p=0.008 |
High HER2 (SI 9) was associated with poor outcome within ER- and/or PR-negative tumours |
28277313 |
androgen receptor (AR) |
PR |
p<0.001 |
AR expression had a positive significant correlation with PR |
28277313 |
androgen receptor (AR) |
ER |
p=0.037 |
AR expression had a positive significant correlation with ER |
26362938 |
ANXA2 |
PR |
p<0.05 |
The expression rate of ANXA2 in the PR-negative group (100 % [43/43]) was significantly higher than the PR-positive group (86.2 % [25/29] |